DE VECCHIS, LIANA
 Distribuzione geografica
Continente #
NA - Nord America 9.152
EU - Europa 668
AS - Asia 193
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 10.016
Nazione #
US - Stati Uniti d'America 9.149
DE - Germania 193
UA - Ucraina 135
CN - Cina 100
IT - Italia 80
IE - Irlanda 79
GB - Regno Unito 39
FR - Francia 36
FI - Finlandia 27
KR - Corea 26
RU - Federazione Russa 25
SE - Svezia 25
SG - Singapore 20
JP - Giappone 16
BE - Belgio 14
IN - India 8
KG - Kirghizistan 8
VN - Vietnam 8
CZ - Repubblica Ceca 6
PL - Polonia 4
AL - Albania 3
CA - Canada 2
EU - Europa 2
HK - Hong Kong 2
CL - Cile 1
ES - Italia 1
IL - Israele 1
IR - Iran 1
LV - Lettonia 1
MX - Messico 1
PH - Filippine 1
TR - Turchia 1
TW - Taiwan 1
Totale 10.016
Città #
Woodbridge 2.831
Houston 2.362
Wilmington 2.324
Ann Arbor 324
Fairfield 213
Chandler 212
Ashburn 135
Jacksonville 129
Cambridge 76
Dublin 73
Seattle 62
Beijing 58
Medford 57
New York 54
Rome 40
Dearborn 35
Lawrence 28
Mülheim 22
Moscow 16
Brussels 14
Falls Church 11
Singapore 11
Redwood City 9
San Diego 9
Menlo Park 8
Milan 8
Boardman 7
Nürnberg 7
Zhengzhou 7
Nanchang 6
Nanjing 6
Brno 5
Kunming 5
Mountain View 5
Pune 5
San Giuliano Milanese 5
Del Norte 4
Dong Ket 4
Engelhard 4
Guangzhou 4
Hanoi 4
Kraków 4
London 4
Palo Alto 4
University Park 4
Castelfidardo 3
Hefei 3
Norwalk 3
Phoenix 3
San Mateo 3
Florence 2
Hong Kong 2
Indiana 2
Jinan 2
Munich 2
Nuremberg 2
Redmond 2
Saint Petersburg 2
Shanghai 2
Siena 2
Tappahannock 2
Tipperary 2
Toronto 2
Verona 2
Villanuova sul Clisi 2
Washington 2
Auburn Hills 1
Baotou 1
Boston 1
Cattolica 1
Changsha 1
Chicago 1
Hyderabad 1
Iglesias 1
Istanbul 1
Kilkenny 1
Lappeenranta 1
Little Rock 1
Los Angeles 1
Madrid 1
Mexico City 1
Mount Clemens 1
Osaka 1
Otrokovice 1
Palermo 1
Riga 1
Salt Lake City 1
San Francisco 1
Secaucus 1
Shenyang 1
Tehran 1
Totale 9.287
Nome #
Focus on Fotemustine 438
Combined effects of protein kinase inhibitors and 5-fluorouracil on CEA expression in human colon cancer cells 438
Drug-induced increase of carcinoembryonic antigen expression in cancer cells 426
Circulating tumor cells in colorectal cancer patients 413
Decline of natural cytotoxicity of human lymphocytes following infection with human T-cell leukemia/lymphoma virus (HTLV) 408
Adjuvant treatment of breast cancer: a pilot immunochemotherapy study with CMF, interleukin-2 and interferon alpha 407
Staurosporine increases carcinoembryonic antigen expression in a human colon cancer cell line 403
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 403
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not). 403
Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy 397
Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro 395
Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy 391
Pharmacological modulation of carcinoembryonic antigen in human cancer cells: studies with staurosporine 384
Effect of the combined treatment with 5-fluorouracil, gamma-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells 382
Endocrine side effects induced by immune checkpoint inhibitors. 379
Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro 376
Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy 373
Immunological aspects of infection with human T cells leukemia/lymphoma virus (HTLV) 360
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro 355
Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro 352
Susceptibility of lymphoma cells bearing human T leukemia/lymphoma virus (HTLV) to NK-mediated cytolysis 349
In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restricted peptides derived from human thymidylate synthase 348
Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer. 329
Drug-induced changes of carcinoembryonic antigen expression in human cancer cells: Effect of 5-fluorouracil 324
Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease. 319
Development of a novel in vitro chemosensitivity assay: telomerase as a possible marker of tumor cell survival 317
Drug-induced neoantigen: a new horizon in cancer immunotherapy? 116
Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment? 72
In vitro chemosensitivity of neoplastic cells: Telomerase as a possible marker of tumor cell survival 4
Totale 10.061
Categoria #
all - tutte 16.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.747


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.608 222 236 178 228 224 277 226 230 216 211 162 198
2020/20211.500 165 180 140 211 150 158 216 155 35 15 60 15
2021/2022286 10 28 10 21 10 33 15 20 15 28 11 85
2022/2023463 36 46 10 84 34 96 24 27 55 1 36 14
2023/2024238 18 7 9 9 21 89 23 16 3 0 4 39
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 10.061